Pharma Focus Asia
KP - Choose our fully recyclable blister films

Archer, Inc Launches Next-Generation Sequencing (NGS) Device to Identify NTRK Gene Fusions in Cancer

ArcherDX, Inc has discovered a new next-generation sequencing (NGS) device to detect Neurotrophic Receptor Tyrosine Kinase (NTRK) gene fusions that leads to the formation and growth of cancer.

The role of Companion Diagnostic (CDx) is to indicate Neurotrophic Receptor Tyrosine Kinase (NTRK) gene fusions, thus helping to prevent the growth of cancers.

Usually  it’s very tough to detect NTRK gene fusions in cancers, hence with the help of newly designed next-generation sequencing technology which makes use of RNA to provide sensitive NTRK fusion detection makes easier without requiring prior knowledge of fusion partners for any solid tumour.

The newly developed NGS technology makes use of advanced Anchored Multiplex PCR (AMP) chemistry which captures DNA, RNA or ctDNA from both blood and tissue samples irrespective of the location of the tumour.

This breakthrough technology allows diagnostics for patients in community and regional settings where  there  is shortage of  infrastructure and expertise to implement sophisticated genomic analysis.

ArcherDX recently announced a collaboration to develop an NGS-based CDx for a TRK inhibitor.

Next-generation sequencing (NGS) device also received the U.S. Food and Drug Administration’s (FDA’s) breakthrough device designation.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayMerck - Mobius® productsThermo Fisher Scientific - Peptones5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024